An Improved Spectrophotometric Procedure for the Determination of Urinary Metanephrines by Stroes, J. W. et al.
Stroes et al.: Improved spectrophotometric procedure for urinary metanephrines 483
J. Clin. Chem. Clin. Biochem.
Vol. 25, 1987, pp. 483-486
© 1987 Walter de Gruyter & Co.
Berlin · New York
An Improved Spectrophotometric Procedure for the
Determination of Urinary Metanephrines
By 7. W. Stroes, J. Putters and H. J. M. van Rijn
Clinical and Haematological Laboratory, Dr. A. Mathijsen Hospital, Utrecht, The Netherlands
(Received January 5/April 30, 1987)
Summary: Spectrophotometric assays for urinary metanephrines are still widely used because of the simple
equipment needed. These methods, however, have the major drawback of being very susceptible to interfer-
ence. Using the original Pisano technique (Pisano, J. J. (1960) Clin. Chim. Acta 5, 406—414) we have often
observed overestimation of the metanephrine concentration. By measuring absorbances at three different
wavelengths we were able to considerably reduce this positive bias. With many patients this resulted in a
significant downward adjustment of the values found for the total metanephrine excretion.
Introduction
Measurement of urinary metanephrines is probably
one of the most reliable methods for the diagnosis öf
phaeochromocytoma (1—4). Although only about
0.04% (4) to 0.6% (1) of hypertensive patients suffer
from this catecholamine-secreting tumotir, exclüsion
of this possibility is extreinely important, because
unrecognised phaeochromocytoma often leads to fa-
tal complications.
In the last decade many sophisticated techniques like
high performance liquid ehromatography, mass spec-
trometfy and radio-immuno assays have been em-
ployed in assessing nanomolar concentrations of cate-
chplamines and their derivatives (5 — 10). However
the expeiisive equipjnent needed is not within the
reach of every laboratory. Fbf this reason the simple
colorimetiic assay developed by Pisano (11) is still
being used. In this assay metanephrines are converted
to vanillin after hydrolysis and subsequent Separation
by ion-exchange chroinatography. Vanillin is meas-
ured spectrophotometrically. Since the maximal ab-
sorbance at 347 nm lacks specificity, the concentra-
tion is usually calculated from the absorbance at 360
nna, a wavelength less susceptible tp interference.
Although this reduces the number of erroneously
high results, we still observed slight to significant
overestimation of the daily secretion in many urines
containing small amounts of metanephrines.
Determination of urinary metanephrines is used äs a
screening procedure: clearly excessive metanephrine
excretion is seldom found. Unfortunately the border-
line between "normal" and "elevated" is not always
distinct. It has been reported that metanephrine ex-
cretion in some patients with proven phaeochromocy-
toma can be very close to the normal ränge (2, 6, 12),
especialiy in patients with intermittent hypertension.
Overestimation of the excretion in "normal" urines
wpuld result in an extension of the grey zone in
which diagnosis cannot be ascertained on biochemical
grounds. For this reason, a slight overestimination
of the metanephrine excretion can definitely be of
clinical importance, even when the result is still within
the normal ränge. By means of a method of calcula-
tion based on the absorbance at three different wave-
lengths we were able to reduce this positive bias
considerably. Moreover, applying this method to the
modified Pisano technique in our laboratory led to
the "normal values" being adjusted downwards, thus
reducing the number of results which might have
introduced an element of doubt in the diagnosis.
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Materials and Methods
Urinc samples were collected for 24 hours in bottles containing
30 ml 4mol/l HCl. Aliquots representing 1/200 of the 24-
hour volume in duplicatc and 5 ml of Standards (42.8 μπιοΐ/ΐ
mclanephrine · HCl) in triplicate were hydrolysed, separated
by ion-exchange chromatography on Amberlite CG-50 and
treated wilh NaIO4 and Na2S205 according to the orginal
Pisano method (11), with the minor modifications suggested by
Croul el al. (13).
All reagents were purchased from Merck (Darmstadt, FRG),
except for Z>,L-metanephrine hydrochloride, jp-hydroxybenzal-
dehyde and Z),L-octopamine which were obtained from Sigma
Chemical Co. (St. Louis. MO, USA) and Amberlite CG-50
which was obtained from Serva (Heidelberg, FRG).
Absorbance spectra were recorded using a Spectronic 2000 UV/
Vis spectrophotometer (Bausch & Lomb Anaiytical Systems
Div., Rochester NY, USA), scan speed 200 nm/min, slit width
2 nm, lamp change (tungsten to deuterium) 380 nm. Data
(wavelength and corresponding absorbance) were transmitted
through a RS-232 interface to a HP-85 microcomputer (Hewlett
Packard Co, Corvallis OR, USA). The absorbance after sub-
traction of the blank (urine not treated with NaIO4) was used
for calculations. Results were obtained after correction for
recovery by use of the Standards.
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Fig. 1. Absorbance spectrufn of 1.6 μιηοΐ/ΐ Vanillin (-—) and
the absorbance spectrum of a mixture f 1.6 μπιοΙ/1
vanillin and 10.7 μιηοΐ/ΐ /?-hydroxybenzaldehyde (---)
in4mol/lNH4OH.
Results and Discussion
Normetanephrine and metanephrine are both con-
verted to vanillin by treatment with NaIO4 in 4 mol/1
NH4OH. This compound yields a broad absorption
band with a maximum at approximately 347 nm.
Measurements are usually made at longer wave-
lengths, i. e. 360 nm, to reduce the influence of inter-
fering substances. Nevertheless, due to the shallow
absorbance curve of vanillin it is not surprising that
some compounds which are eluted with metanephrine
are known to interfere with the metanephrine deter-
mination. Especially octopamine, which reacts in the
same way with NaIO4 s metanephrine, yielding p-
hydroxybenzaldehyde with a maximum at 333 nm, is
a known interferent. Where this compound is present
in appreci ble amounts, measurement at 360 nm
easily leads to considerable overestimation of the
metanephrine concentration (fig. 1). For tbis reason,
Crout et al. (l 3) suggested that urines with an absorb-
ance at 360 nm exceeding 0.063 (corresponding to
5 μιηοΐ metanephrine per 24 hours) should also be
measured at 347 and 333 nm in order to establish
whether the high reading is due to vanillin or to an
interfering substance with a maximum at a shorter
wavelength, presumably /7-hydroxybenzaldehyde.
This procedure is useful in detecting erroneously high
results, but it does not satisfy the requirement for
reliable quantitative results where such interference
is present. Other interfering compounds could be
synephrine, which has been identified in bovine adre-
nal gland (15) and /?-hydroxy-mandelic acid which
can be demonstrated in human urine (15). However,
after oxidation with sodium metaperiodate these sub-
stances are also converted to /7-hydroxybenzaldehyde,
which allows the elimination of interference from
three compounds by determination of one mutual
oxidation product.
It appeared that virtually all spectra could be de-
scribed satisfactorily s a mixture of vanillin, p-hy-
droxybenzaldehyde and a constant background ab-
sorption. These three variables can be adequately
calculated from the absorbances at three different
wavelengths. Absorbances of the pure compounds
were determined, which resulted in three equations:
A4oonm = Ο χ [vani] 4· Ο χ [pOHbenz] + c
A360 = 0.0227 χ [vani] + 0.0037 χ [pOHbenz] + c
A333 = 0.0203 χ [vani] + 0.0268 χ [pOHbenzj -h c
where [vani] = vanillin concentration in μπιοΙ/1
[pOHbenz] = p-hydroxybenzaldehyde concentration
in μηιοΐ/ΐ
c = constant
Measurement at 400 nm proves to be important in
eliminating the influence from background absorp-
tion. Since the absorbance of vanillin or /j-hydr xy-
benzaldehyde is virtually zero at this wavelength, the
"c" in r equations equals the resulting absorbance
at 400 nm. The concentration of vanillin and p-
hydroxybenzaldehyde can be calculated from the re-
maining two equations by simple elimination of un-
known variables, followed by correction for recovery
and for dilution caused by the addition of NaIO4 and
Na2S2O5.
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In our laboratory the measured /?-hydroxybenzal-
dehyde concentrations were 5.0 ± 6.0 μπιοΙ/24 h
(mean ± SD; n = 39). Unfortunately we were not
able to determine the relative contributions of octop-
amine, synephrine and /7-hydroxy-mandelic acid. The
normal excretion of octopamine (0.34 ±0.16 μιηοΐ/
24h; 16) and synephrine (less than 0.26 μιηο1/241ι;
15) cannot explain these/7-hydroxybenzaldehyde con-
centrations. On the other band, /?-hydroxy-mandelic
acid with a normal daily excretion of 12.6 ± 4.7
μηιοΐ/ΐ for females and 17.2 + 8.6 μιηοΐ/ΐ for males
(l 5) could explain high /?-hydroxybenzaldehyde con-
centrations.
This however seems unlikely for the following reason.
Amberlite CG-50 is a cation exchanger, which binds
the metanephrines, and octopamine and synephrine,
via their nitrogen groups.
Chromatographie recovery of 3,4-dihydroxyphenyl-
mandelic acid from plasma is 67 ± 2.9% on a Nu-
cleasil C18 colomn coated with tri-n-butyl-phosphate
(17), which retains carboxylic acids. Precautions were
taken to avoid decomposition of the labile 3,4-dihydr-
oxyphenyl-mandelic acid and elution was performed
at pH 3.
Because a metanephrine excretion close to 5 μπιοί per
24 hours, i. e. the upper limit of normal metanephrine
excretion, might leave doubts in reaching a diagnosis
when phaeochromocytoma is strongly suspected on
clinical grounds, we also adopted this calculation for
urines showing absorbances at 360 nm below 0.053.
This often resulted in a considerable downward ad-
justment f the metanephrine excretion: many values
close to or just above 5 μπιοί per 24 hours were
reduced to clearly normal results. Reference values
s determined with our method were also reduced
considerably compared with values derived solely
from the absorbarice at 360 nm. In our laboratory,
the mean 24-hour excretion for normotensive and
hypertensive patients together was reduced from 2.8
± 1.3 μηιοί to 1.6 ± 0.8 μπιοί (n = 39). The refer-
ence values found do not differ from results in the
literature, obtained with iti re sophisticated tech-
niques (tab. 1). In cpntrast, reference values found
with the .orginal Pisano technique or modifications
thereof (11-14) are consistently higlier (tab. 1). It
appeared that metanephrines in urine samples. of
patients mcluding patients with proven phaeochro=r
mocytoma s determined with gas chromatography
according to the method of Muskiet (5) correlated
well with the metanephrine values s determined with
the present method. A correlation coefficient
r = 0.998 was found in 7 urine samples with values
in the r nge between 1.1 — 102.6 μπιοΐ/ΐ.
Tab. 1. Mean urinary melanephrine excretion in non-phaeo-
chromocytoma patients.
Methods used*
GC/MS
RIA
MS
HPLC
HPLC
RIA
Pisano technique
Pisano technique
Pisano technique
Pisano technique
Our method
Reference
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
(13)
(14)
Metanephrine
(x ± s)
μπιοΙ/24 h
1.0 + 0.4**
0.5 + 0.2
2.0
1.4
1.7 + 0.2
2.0 ± 1.0
3.2 + 1.6
4.5 ± 2.4
3.3 ± 1.5
3.5 ± 1.5
1.6 + 0.8
GC = gas chromatography
MS = mass spectrometry
RIA = radioimniunoassay
HPLC = high performance liquid chromatography
values were given s 1.5 ± 0.6 μιηοΐ/g creatinine which
converts to 1.0 ± 0.4 μπιοΙ/24 hours, assuming a daily
excretion of 1500 mg creatinine.
The upper limit for normal metanephrine excretion
s determined with the Pisano technique is usually
taken s 5 μπιοί per 24 hours (12, 13). Three out of
39 samples in our laboratory exhibited values just
above this limit when determined from the absorb-
ance at 360 nm; all of them were reduced to values
below 3 μιήοΐ/ΐ with our method of calculation. The
upper limit of normal with our method appears to
be considerably lower: no values above 3.2 μηιοί per
24 hours have been observed yet.
In conclusion we believe that our adaptation of the
method of calculation of the vanillin concentration
will greatly contribute to the reliability and diagnostic
accuracy of spectrophotometric assays for total meta-
nephrines. Recoveries for metanephrine were deter-
mined by adding 0.5 ml stock Solutions to 10 ml
po led urine. The endogenous metanephrine concen-
tration was increased 0—10 μιηοΐ/ΐ by the stock addi-
tions. These samples were hydrolysed and assayed
s described in the materials and methods section.
Metanephrine was recovered to the extend of 99.7
+ 23.5% (n = 6), in agreement with reports from
other authors (11,14). The high value of the Standard
deViatiori is the result of the wide r nge (0-10
μπιοΐ/ΐ) of metanephrine concentrations, and the low
number of determinations.
Because of the simple equipment needed, this modifi-
cation of the original Pisano technique (11) provides
a screening method for phaeochromocytoma that is
suitable for even small laboratories.
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